首页 | 本学科首页   官方微博 | 高级检索  
     

Notch3调控Hes2逆转三阴性乳腺癌上皮-间质转化的机制研究
引用本文:田园,牟雅君,杨文秀,豆晓伟. Notch3调控Hes2逆转三阴性乳腺癌上皮-间质转化的机制研究[J]. 天津医药, 2022, 50(8): 785-790. DOI: 10.11958/20220306
作者姓名:田园  牟雅君  杨文秀  豆晓伟
作者单位:1贵州医科大学临床医学院病理教研室(邮编550004)2贵州医科大学附属医院临床研究中心
基金项目:国家自然科学基金资助项目(81860516);
摘    要:目的 探究Notch3逆转三阴性乳腺癌(TNBC)上皮-间质转化(EMT)及抑制肿瘤转移的分子机制。方法 将Notch3过表达质粒(pcDNA3.1-Notch3-GFP)及其阴性对照质粒(pcDNA3.1-NC-GFP)、Hes2敲低的小分子干扰质粒(si-Hes2-GFP)及其阴性对照质粒(si-NC-GFP)转染...

关 键 词:三阴性乳腺癌  上皮-间质转化  Notch3  Hes2  MDA-MB-231细胞  肿瘤转移
收稿时间:2022-03-03
修稿时间:2022-04-18

The mechanism of Notch3 regulating Hes2 to reverse epithelial-mesenchymal transition in triple-negative breast cancer
TIAN Yuan,MOU Yajun,YANG Wenxiu,DOU Xiaowei. The mechanism of Notch3 regulating Hes2 to reverse epithelial-mesenchymal transition in triple-negative breast cancer[J]. Tianjin Medical Journal, 2022, 50(8): 785-790. DOI: 10.11958/20220306
Authors:TIAN Yuan  MOU Yajun  YANG Wenxiu  DOU Xiaowei
Affiliation:1 Department of Pathology, School of Clinical Medicine, Guizhou Medical University, Guiyang 550004, China
2 Clinical Research Center, the Affiliated Hospital of Guizhou Medical University
Abstract:Objective To explore the molecular mechanism of Notch3 reversing epithelial-mesenchymal transition (EMT) and inhibiting tumor metastasis in triple negative breast cancer (TNBC). Methods The Notch3 overexpression plasmid (pcDNA3.1-Notch3-GFP) and its negative control plasmid (pcDNA3.1-NC-GFP), the small molecule interference plasmid for Hes2 knockdown (si-Hes2-GFP) and its negative control plasmid (si-NC-GFP) were transfected into TNBC MDA-MB-231 cells. Cells were divided into the control group (no transfection was performed), the pc-NC group (transfection pcDNA3.1-NC-GFP), the Notch3 overexpression group (pc-Notch3 group, transfection pcDNA3.1-Notch3-GFP), the Notch3 overexpression+si-NC group (pc-Notch3+si-NC group, co-transfected pcDNA3.1-Notch3-GFP and si-NC-GFP), and the Notch3 overexpression+Hes2 knockdown group (pc-Notch3+si-Hes2 group, co-transfected pcDNA3.1-Notch3-GFP and si-Hes2-GFP). Real-time quantitative PCR and Western blot assay were performed to measure mRNA and protein expression levels of Notch3 and Hes2 in cells to verify the transfection efficiency. The cell counting kit-8 assay was performed to measure cell proliferation activity. Scratch healing assay and Transwell chamber assay were performed to measure cell migration and invasion abilities. Western blot assay was performed to measure EMT-related proteins (E-cadherin and Vimentin) in cells. Results Compared with the control group and the pc-NC group, the Notch3, Hes2 mRNA and protein, E-cadherin protein levels were significantly increased in the pc-Notch3 group and the pc-Notch3+si-NC group, and the proliferation activity, mobility, number of transmembrane cells and Vimentin protein levels were significantly decreased (P<0.05). Compared with the pc-Notch3 group and the pc-Notch3+si-NC group, the Hes2 mRNA and protein levels and E-cadherin protein were significantly decreased in the pc-Notch3+si-Hes2 group, and the proliferation activity, mobility, number of transmembrane cells and Vimentin protein levels were significantly increased (P<0.05). Conclusion Notch3 may reverse the EMT of TNBC and inhibit tumor metastasis by up-regulating Hes2.
Keywords:triple negative breast neoplasms  epithelial-mesenchymal transition  Notch3  Hes2  MDA-MB-231 cells  tumor metastasis  
点击此处可从《天津医药》浏览原始摘要信息
点击此处可从《天津医药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号